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dosonographically guided drainage was inserted via the 
gastric or the duodenal wall. After communication between 
the separate drains had been proven, an external to internal 
directed high-volume lavage with a daily volume of 500 ml 
up to 2,000 ml was started.  Results: In all patients, pancre-
atic necrosis/liquid collections could be resolved completely 
by the presented regime. No patient died in the course of our 
study. After initiation of the directed high-volume lavage, 
there was a significant clinical improvement in all patients. 
Double drainage was performed for a median of 101 days, 
high-volume lavage for a median of 41 days. Several endo-
scopic interventions for stent replacement were required 
(median 8). Complications such as bleeding or perforation 
could be managed endoscopically, and no subsequent sur-
gical therapy was necessary. All patients could be dismissed 
from the hospital after a median duration of 78 days.  Conclu-
sion: This approach of combined percutaneous/endoscopic 
drainage with high-volume lavage shows promising results 
in critically ill patients with extended infected pancreatic ne-
crosis and high risk of surgical intervention. Neither surgical 
nor endoscopic necrosectomy was necessary in any of our 
patients. 
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 Abstract 
 Background: Infection of pancreatic necrosis is a life-threat-
ening complication during the course of acute pancreatitis. 
In critically ill patients, surgical or extended endoscopic in-
terventions are associated with high morbidity and mortal-
ity. Minimally invasive procedures on the other hand are of-
ten insufficient in patients suffering from large necrotic 
areas containing solid or purulent material. We present a 
strategy combining percutaneous and transgastric drainage 
with continuous high-volume lavage for treatment of ex-
tended necroses and liquid collections in a series of patients 
with severe acute pancreatitis.  Patients and Methods: Sev-
en consecutive patients with severe acute pancreatitis and 
large confluent infected pancreatic necrosis were enrolled. 
In all cases, the first therapeutic procedure was placement of 
a CT-guided drainage catheter into the fluid collection sur-
rounding peripancreatic necrosis. Thereafter, a second en-
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 Introduction 
 Among patients with acute pancreatitis, up to 15% will 
have a severe course of the disease. Severe acute pancre-
atitis (SAP) is still associated with a significant morbidity 
and mortality ranging from 10–42%  [1] . The early phase 
of acute pancreatitis is characterized by an inappropriate 
activation of pancreatic enzymes inside the organ. In se-
vere cases, destruction of pancreatic tissue is parallel to 
local inflammation which progresses to a systemic in-
flammatory response syndrome, often with multi organ 
failure  [1] . A second peak of the disease is predominantly 
caused by infectious complications, namely infection of 
necrosis  [2] . As classified by the International Symposium 
on Acute Pancreatitis in Atlanta, on contrast-enhanced 
CT, the necrotic pancreatic tissue presents as diffuse or 
focal area with decreased or missing contrast enhance-
ment compared to normal pancreatic parenchyma  [3] . 
Necrosis may extend far beyond the margins of the pan-
creas. Infection of the necrotic tissue should be considered 
in case of fever  6 38.5 ° C, leukocytosis, increasing plasma 
C-reactive protein (CRP) or rapid clinical deterioration. 
Signs of gas inclusion in pancreatic or extrapancreatic ne-
crosis are highly suspicious for infection  [4] .
 In general, treatment of necrotizing disease is based on 
removal of the necroses and prophylactic antibiotic ther-
apy. Nevertheless, particularly in necrotizing pancreati-
tis, the benefit of surgery as well as antibiotics is matter of 
an ongoing debate  [5, 6] . Concerning antibiotics, the two 
largest and recent studies failed to demonstrate signifi-
cant benefits  [2, 7] . However, this might be due to the lim-
ited number of patients with severe pancreatitis as well as 
inter-current antibiotics in the ‘placebo’ group due to oth-
er indications than necrotizing pancreatitis. Unexpect-
edly, the infectious potential of necroses was underlined 
by the results of a recent trial on probiotics in necrotizing 
pancreatitis  [8] . This underlines the importance of suffi-
cient and fast removal of necrotic tissue.
 The aim of all therapeutic strategies in infected pancre-
atic necrosis is to remove necrotic material and surround-
ing fluid collections. This leads to a decrease in concentra-
tion of digestive enzymes, proinflammatory mediators 
and endotoxins, and thereby stops the progress of infec-
tion  [9] . Surgical strategies have combined necrosectomy 
with extensive continuous or repeated lavage  [10–12] . 
However, due to the operative stress in critically ill pa-
tients, surgical approaches have been associated with high 
morbidity and mortality (20–30%). Furthermore, about 
two thirds of patients developed long-term complications, 
making repeated laparotomies necessary (17–71%)  [13–
17] . For that reason, treatment of infected pancreatic ne-
crosis has progressively been shifted from surgical to non-
surgical strategies, particularly in sterile necroses  [5] . 
Whereas there are few data on nonsurgical management 
of infected necroses, these approaches normally apply dif-
ferent numbers of percutaneous and endoscopic drainag-
es (percutaneous, transgastric, transduodenal, transpap-
illary), mostly in combination with repeated irrigations or 
endoscopic necrosectomies. Single endoscopic procedures 
are often insufficient in treatment of huge necrotic areas 
containing large amounts of solid or purulent necrotic 
material  [18–20] . In these cases, repeated necrosectomies 
with the risk of losing vital pancreatic tissue and of caus-
ing severe bleedings are required  [21] .
 To overcome this problem, we aimed to combine a 
strategy of continuous directed high-volume lavage from 
external percutaneous to internal transgastric drainages 
to resolve necrotic material and limit local infection in 
critically ill patients with SAP and infected pancreatic 
necrosis. In this case series, we report on feasibility and 
outcome of this concept in critically ill patients with ex-
tended pancreatic necroses and fluid collections.
 After initial experience in 3 patients, a consensus on 
future management of patients with extended necroses 
accessible to both radiologic as well as endoscopic drain-
age was established.
 Patients and Methods 
 In a time period of 31 months, 7 consecutive patients (3 wom-
en, 4 men) with SAP and infected pancreatic necrosis were ana-
lyzed. The etiologies of pancreatitis were the following: biliary in 
5 patients, alcoholic in 1 patient and idiopathic in 1 patient. Pa-
tient demographics, duration of drainage therapy, complications 
and outcome are shown in  tables 1 and  2 . All patients were criti-
cally ill (median APACHE II score: 11), had extensive necrosis and 
high risk towards surgical intervention.
 Therapy Regime 
 In the first few days of acute pancreatitis, all patients were 
treated with high-volume fluid resuscitation and intravenous an-
algetics. No prophylactic antibiotics were used. Subsequently, in 
case of fever  6 38.5 ° C, rapidly increasing leukocytosis, plasma 
CRP or clinical deterioration, antibiotic treatment with imipenem 
was started and abdominal contrast-enhanced CT was performed. 
If necrosis was revealed, a CT-guided drainage catheter (12F; Bos-
ton Scientific International, Natick, Mass., USA) was placed in the 
same session ( fig. 1–3 ). ‘Low-volume’ irrigation was started with 
40 ml saline solution every 4 h. Additionally, within the next days, 
an endosonographically guided drainage was inserted through 
the gastric or the duodenal wall. Endoscopic ultrasound was used 
to define the optimal puncture position and to exclude vessel in-
terposition. Therefore, a curvilinear echoendoscope (Olympus, 
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Hamburg, Germany) and a puncture system (Boston Scientific In-
ternational) were used. The necrotic areas with surrounding fluid 
collections were punctured with a 22-gauge needle. Liquefied ma-
terial or pus were aspired for bacteriologic examination and resis-
tance testing. Using the puncture device, one or two 7 F pigtail 
catheters were placed. Contrast medium was injected to evaluate 
extension of the cavity and to prove continuity of the necrotic cav-
ity between the transcutaneous and internal drainages. If com-
munication of fluids between the drains could be demonstrated, 
high-volume lavage irrigation from the percutaneous to the endo-
scopically placed catheter with a daily volume of 500 ml up to 
2,000 ml was started ( table 1 ) avoiding infusion pumps by using a 
gravity-driven infusion (40 cm H 2 O above symphysis).
 Declining size of the cavity as well as significant clinical im-
provement were used as parameters for drain removal. First, the 
percutaneous drainage was removed. Four of 7 patients were dis-
missed from the hospital with the transgastric/transduodenal 
drainage in situ. All patients were monitored in short intervals by 
clinical presentation, ultrasound examination and laboratory 
tests. The transgastric/transduodenal drainages were removed 
after a complete resolution of the necrotic area.
 Results 
 In all patients, percutaneous as well as transgastric/
transduodenal drainages could be applied without any 
complications during endoscopic procedures. In 4 pa-
tients, a transgastric drainage was placed. Three patients 
received transduodenal pigtail catheters.
 In each patient, fluid collections containing large 
amounts of solid necrotic material and pus were evacu-
ated after insertion of the CT-guided percutaneous drain-
age. Prior to intervention in 2 of 7 patients, presence of 
bacteria  (Escherichia coli, Enterococcus faecium) was 
proven in the blood during ongoing therapy with imipe-
nem. In the effluate, bacteria were detected in all 7 pa-
tients ( table 2 ). Antibiotic therapy was adjusted according 
to resistance testing. With the ‘low-volume’ lavage of 40 
ml saline every 4 h, the effluates remained viscous con-
taining large amounts of solid necrotic material and pus. 
Table 1. Patient demographics and therapy regime
Case/
gender 
Age, 
years
Etiology Drainage Duration of double
drainage, days
Complications Maximum
lavage, ml/day
Endoscopic
procedures
Hospi-
talization, days
Outcome
1/M 66 biliary transduodenal 150 perforation
duodenum
500 16 150 completely 
resolved
2/F 55 biliary transgastric 154 500 14 89 completely 
resolved
3/M 75 other transduodenal 8 500 7 45 completely 
resolved
4/M 73 biliary transgastric 75 colonic fistula 1,500 16 61 completely 
resolved
5/F 84 biliary transduodenal 125 bleeding 1,500 14 54 completely 
resolved
6/M 42 alcoholic transgastric 65 retroperitoneal
fistula
2,000 21 74 completely 
resolved
7/F 35 biliary transgastric 132 2,000 16 74 recurrent 
pseudocysts
Table 2. Patient data
Case Extent of pancreatic
necrosis, mm
Days from onset of
symptoms to intervention
Bacteriology CRP at the time of
intervention, mg/dl
APACHE II
score
1 120!55 18 Klebsiella pneumoniae 33 19
2 100!50 24 Enterococcus faecium 28 12
3 86!52 30 Escherichia coli 30 8
4 80!60 28 Enterococcus faecium 29 8
5 130!80 21 Pseudomonas aeruginosa 34 10
6 90!80 27 Klebsiella pneumoniae 28 10
7 80!50 20 Escherichia coli 36 11
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After endoscopic ultrasound-guided transgastric/trans-
duodenal drainage, a directed high-volume lavage from 
the percutaneous drainage to the internal drainage was 
started with a daily amount of 500–2,000 ml. After ini-
tiation of the directed high-volume lavage, there was a 
significant improvement with respect to clinical condi-
tion and infective parameters in all patients ( fig. 4 ).
 During drainage therapy, episodes of fever and drain 
occlusions or dislocations occurred. Therefore, several 
endoscopic interventions for drainage replacement were 
required. The median number of reinterventions was 8 
( table 1 ). In 1 patient, a spontaneous duodenal perfora-
tion occurred (patient 1), 1 patient developed a pancre-
atico-colonic fistula (patient 4), a 3rd patient developed a 
fistula to the retroperitoneal space (patient 6). A sponta-
neous gastric bleeding occurred in patient 5. However, all 
complications could be managed endoscopically. Infec-
tions during drainage therapy were treated according to 
the results of microbiological testing acquired from the 
effluate. Fistulas had spontaneous closure and no recur-
rence was observed during follow-up. No subsequent sur-
gical therapy was necessary. High-volume lavage did not 
affect any clinical complications such as profuse diar-
rhea. During the stay on intensive care unit, patients re-
ceived total parenteral nutrition. Enteral feeding using a 
nasogastric tube was started with clinical improvement. 
Temporarily, both methods parenteral nutrition as well 
as nasojejunal feeding were necessary.
 The median duration of high-volume lavage was of 41 
days, the duration of double drainage 101 days. All patients 
could be dismissed from the hospital after a median dura-
tion of 78 days. If necessary, drainage therapy was contin-
 Fig. 3. CT scan with percutaneous (1) and transgastric (2) drain-
age. High-volume lavage was directed from the percutaneous to 
the endoscopically placed catheter. 
 Fig. 2. CT scan before intervention with infected pancreatic ne-
crosis (yellow arrow) after biliary stent placement (white arrow). 
Red arrow shows multiple gallstones and air in lumen of gallblad-
der. 
 Fig. 1. Schematic illustration of combined percutaneous and transgastric drainage regime. 
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ued in an outpatient regime. Subsequently, the patients 
were monitored in short intervals for clinical presentation, 
ultrasound examination and laboratory tests. In all pa-
tients, a complete remission of all visible abscess cavities 
was achieved. All drains were removed endoscopically. At 
a minimum follow-up of 10 months, all patients showed a 
complete resolution of the necrotic areas. One patient (pa-
tient 7) suffered from recurrent pancreatic pseudocysts, 
which were drained endoscopically. Two of the 7 patients 
developed exocrine insufficiency with diarrhea. Pancre-
atic enzyme replacement therapy was started.
 Discussion 
 Here, we present a regimen of percutaneous CT-guid-
ed and transgastric/transduodenal drainage combined 
with directed continuous high-volume lavage in critical-
ly ill patients with severe necrotizing pancreatitis and 
high risk of surgical intervention.
 The main issues concerning treatment of infected 
pancreatic necrosis are removal of solid infected necrotic 
material as well as fluid collections and a consistent re-
duction in concentration of digestive enzymes, pro-in-
flammatory mediators and endotoxins to facilitate heal-
ing and granulation. Surgical approaches require large 
abdominal incisions for open necrosectomy. This is fol-
lowed by insertion of multiple external drainage cathe-
ters. These large catheters enable effective continuous 
high-volume lavage to remove residual necrotic tissue 
and infected debris  [10] . The benefit of continuous high-
volume lavage in this context is generally accepted  [10] . 
However, due to high peri- and postoperative stress of 
open necrosectomy, surgical approaches are associated 
with high morbidity and mortality in critically ill pa-
tients ranging between 15 and 30%  [16] .
 The rationale of percutaneous/endoscopic procedures 
is to minimize the peri- and postoperative stress in criti-
cally ill patients. Therefore, less invasive surgical tech-
niques such as minimal access surgery have been devel-
oped. The results of these approaches, with a lower inci-
dence of postoperative organ failure when compared with 
open surgery, are encouraging  [22] . However, strategies 
avoiding surgery by using only drainage catheters and 
repeated irrigations often fail in completely resolving in-
fected necrotic and purulent material. Thus, in most en-
doscopic series, repeated necrosectomies or delayed sur-
gical debridement were necessary  [21, 23] . For endoscop-
ic necrosectomy, complex and time-consuming tech-
niques with large stoma for retroperitoneal endoscopy 
via transgastric fenestration, or aggressive daily endo-
scopic necrosectomies after balloon dilatation are ap-
plied  [20, 21, 23] . However, large stoma are a risk for 
bleeding, free perforation, fistulas or embolism due to the 
presence of eroded vessels. Furthermore, surgical or en-
doscopic necrosectomies are ‘local procedures’ and there-
fore limited in spatial extension. So, in many cases, large 
areas of necrotic material as well as huge fluid collections 
cannot be resolved completely.
 The aim of the presented strategy was to combine the 
effectiveness of continuous high-volume lavage used in 
surgical procedures with the minimally invasive percu-
taneous/endoscopic approach. Our data suggest that 
high-volume lavage, which follows the surgical concept, 
can efficiently reduce the concentration of digestive en-
zymes and proinflammatory mediators. High-volume la-
vage can also physically remove solid necrotic material 
due to the continuous outflow of the remaining necrotic 
tissue. Furthermore, high-volume lavage is not limited to 
local cavities. In all patients presented here, pancreatic 
necrosis and fluid collections could be resolved com-
pletely by directed high-volume lavage, and no addition-
al necrosectomy or delayed surgery was required. This 
suggests that high-volume lavage can be used as a ‘non-
invasive necrosectomy’ in critically ill patients with in-
fected pancreatic necrosis and huge fluid collections. The 
benefit of this approach is highest in patients with severe 
disease and multiple organ failure, because in these pa-
tients minimizing peri- and postoperative stress is essen-
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 Fig. 4. Representative decline of infective parameters (patient 6) 
after directed high-volume lavage from the percutaneous drain-
age to the internal drainage was started (CRP: normal value  ! 0.5 
mg/dl). 
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tial. This might be the reason for the reduced mortality 
in comparison to the surgical management.
 One might argue that large amounts of intra-abdomi-
nal lavage fluid might spread infection, increase fluid col-
lections or raise intra-abdominal pressure. To minimize 
these risks, we limited the perfusion pressure to 40-cm 
water column. High-volume lavage was monitored close-
ly and stopped immediately in case of drain occlusion or 
increase in fluid collections. No episodes of fever were 
assessed after initiation of lavage. Because of the long 
treatment period, detailed evaluation of the effectiveness 
and benefit of high-volume lavage is difficult and reliable 
parameters are missing. Therefore, one might use the 
concentration of digestive enzymes, e.g. lipase concentra-
tion in the effluate. Lipase concentration was monitored. 
During lavage, lipase concentration was reduced more 
than a hundredfold. However, due to the small number 
of patients, the clinical relevance of this specific issue re-
mains unanswered. In future studies, monitoring of pro-
inflammatory cytokines like IL-1, IL-6, IL-8 and TNF-  , 
which are involved in the pathogenesis of acute pancre-
atitis and its systemic complications, might help to an-
swer this question.
 The disadvantage of the presented strategy is the high 
number of endoscopic procedures as well as the long du-
ration of overall treatment. The solid necrotic material is 
a substantial risk for drainage occlusion. Therefore, in 
order to sustain continuous lavage, repeated endoscopic 
procedures to readjust or replace occluded drainages are 
required. However, the use of percutaneous guided drain-
age is safe and generally accepted in the therapy of pan-
creatic pseudocysts. Endosonography allows a precise 
transgastric/duodenal drainage placement with a low 
risk of endoscopy-associated complications  [21] . The long 
duration of hospitalization results from the critical med-
ical condition in all patients and is according to previous 
reports of patients with SAP. Two of the 7 patients devel-
oped long-term complications, namely exocrine pancre-
atic insufficiency, which is in accordance with previous 
studies  [14] . Despite the promising results in this series, 
it should be stressed that treatment of infected pancre-
atic necrosis is still complex and should be performed in 
specialized centers. However, to prove the benefit and 
cost effectiveness of the presented approach, a higher 
number of patients is needed.
 Taken together, the presented strategy combines con-
tinuous high-volume lavage used in surgical procedures 
with a minimally invasive percutaneous/endoscopic ap-
proach in critically ill patients with SAP and infected ne-
crosis. We estimate that high-volume lavage is able to re-
move solid necrotic material without limitation to local 
cavities. Thereby, concentration of digestive enzymes, 
proinflammatory mediators and endotoxins can be re-
duced and progress of infection can be stopped. The dis-
advantage of this approach is the high number of endo-
scopic procedures and the long duration of hospitaliza-
tion. However, this is balanced by avoiding surgery with 
high operative stress and long-term complications. All 7 
patients had a complete resolution of the necrotic area. 
The benefit and cost effectiveness of this approach have 
to be proven in a higher number of patients.
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